Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
July 19, 2024 08:30 ET | Palisade Bio, Inc.
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar...
Logo.png
Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe
June 23, 2023 08:01 ET | Ocean Biomedical, Inc.
Patent notice extends global coverage for breakthrough discovery, with potential for treating Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases, including Scleroderma, Nonalcoholic...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Receives Intention to Grant from European Patent Office for LB1148 Patent
March 01, 2023 09:05 ET | Palisade Bio, Inc.
Carlsbad, CA, March 01, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company”), a clinical stage biopharmaceutical company advancing therapies for acute and chronic...
Logo.png
BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program
February 08, 2023 09:00 ET | BioRestorative Therapies, Inc
--Patent provides protection in key international markets for BioRestorative’s ThermoStem® program targeting obesity and metabolic disorders, including type 2 diabetes-- MELVILLE, N.Y., Feb. 08,...
COGRX Logo.jpg
Cognition Therapeutics Receives European Patent Covering its Alzheimer's Disease Candidate, Elayta™
February 21, 2019 08:03 ET | Cognition Therapeutics, Inc.
Pittsburgh, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative...
IGX Logo Medium Size.jpg
IntelGenx Reports Second Quarter 2018 Financial Results
August 09, 2018 16:17 ET | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 09, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the second quarter...
IGX Logo Medium Size.jpg
IntelGenx Announces Notice of Grant of European Patent Covering  Rizaport® VersaFilm™
June 19, 2018 08:00 ET | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a...
Gopher Protocal.jpg
Gopher Protocol, Inc. Files Patent Application in the European Patent Office
December 15, 2017 08:00 ET | Gopher Protocol, Inc.
SANTA MONICA, CA, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Gopher Protocol, Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage company which specializes in the creation of Internet of...
IP Center Director D
IP Center Director Daryl Lim Invited to Attend High-Level U.S.-Europe Patent Meeting in Munich
October 20, 2017 13:23 ET | The John Marshall Law School
Chicago, Illinois, Oct. 20, 2017 (GLOBE NEWSWIRE) -- Professor Daryl Lim, Director of the Center for Intellectual Property, Information & Privacy Law at The John Marshall Law School in Chicago,...